Cagrili

Cagrilintide 4 mg

Cagrilintide is a long-acting amylin analogue. It works on a separate pathway to GLP-1, and is often combined with Semaglutide in the CagriSema protocol.

What it does

• Amylin receptor activation — separate pathway from GLP-1
• Additive appetite suppression alongside Semaglutide
• One of the rarest compounds available locally
• Once-weekly dosing

How it's delivered

4 mg cartridge. Fits the reusable pen. Subcutaneous, once weekly.

Don't have a pen? Add a Disposable Pen — R125

Takes standard 3 ml cartridges. Or buy the reusable Starter Kit once.